Attached files
| file | filename |
|---|---|
| S-1/A - REGISTRATION STATEMENT - TENAX THERAPEUTICS, INC. | oxbt_s1a.htm |
| EX-5.1 - TENAX THERAPEUTICS, INC. | oxbt_51.htm |
| EX-3.7 - FORM OF CERTIFICATE OF DESIGNATIONS - TENAX THERAPEUTICS, INC. | oxbt_ex37.htm |
| EX-10.72 - FORM OF PLACEMENT AGENCY AGREEMENT - TENAX THERAPEUTICS, INC. | oxbt_ex1072.htm |
| EX-10.73 - FORM OF SECURITIES PURCHASE AGREEMENT - TENAX THERAPEUTICS, INC. | oxbt_ex1073.htm |
| EX-10.71 - FORM OF WARRANT - TENAX THERAPEUTICS, INC. | oxbt_ex1071.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-1, filed on the date hereof, of Oxygen Biotherapeutics, Inc. formerly Synthetic Blood International, Inc. (a development-stage enterprise) (the “Company”) of our report dated June 26, 2013 with respect to the consolidated financial statements of the Company included in the Company’s Annual Report on Form 10-K, for the year ended April 30, 2013, filed on June 26, 2013.
/s/ CHERRY BEKAERT LLP
Raleigh, North Carolina
July 16, 2013